European Lithium Ltd - Issue of Shares
RNS Number : 8594Z
European Lithium Limited
23 September 2020
 

European Lithium Ltd

("European Lithium", "EUR" or "the Company")

Issue of Shares

European Lithium Limited (ASX:EUR, FRA:PF8, VSE:ELI, AQSE: EUR) (the Company) advises that a total of 48,163,643 fully paid shares (the Shares) have been issued. 

 

Of the 48,163,643 Shares, 46,363,643 shares are being issued pursuant to the placement as announced on 22 September 2020.1,800,000 shares are being issued pursuant to a conversion of debt to equity.

 

Application has been made for the Shares to be admitted to trading on AQSE ("Admission"). Admission is expected to occur at 8:00am on or around 28 September 2020. Following Admission, the Company's issued share capital will comprise 717,123,518 ordinary shares of no par value, with each share carrying the right to one vote. The Company does not hold any ordinary shares in treasury.  The above figure of 717,123,518 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or of a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

 

The full ASX announcement can be seen at: https://www.asx.com.au/asx/share-price-research/company/EUR

 

- END -

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014

Visit the Company's website to find out more about the advanced Wolfsberg Lithium Project located in Austria.

For further information please contact:

European Lithium Ltd

+61 861 819 792

Tony Sage

info@europeanlithium.com

 

 

NEX Corporate Adviser

+44 207 220 1666

James Joyce


James Sinclair-Ford




 

This information is provided by RNS, the news service of the . RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NEXGIGDCDBDDGGX ]]>